Primary Site >> Esophagus Cancer

Gene >> ERBB2

Journal: Princess Takamatsu Symp. 1991;22:371-80.
Title: Biological significance of gene amplification in carcinogenesis.
Author: Terada, M|Sakamoto, H|Ohmura, Y|Tsuruta, H|Akiyama, N|Sasaki, H|Katoh, M|Hattori, Y|Yoshida, T
PMID: 1844251
Journal: Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1090-3.
Title: [Cancer metastasis and recurrence from the standpoint of amplification and expression of oncogenes in human malignant tumors].
Author: Kikuchi, K|Ueda, M|Kitagawa, Y|Ando, N|Abe, O
PMID: 1944161
Journal: Int J Cancer. 1992 Jun 19;51(4):548-54.
Title: Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas.
Author: Chang, K|Pastan, I|Willingham, M C
PMID: 1351045
Journal: Anticancer Res. 1993 Sep-Oct;13(5A):1293-301.
Title: Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Author: Shiga, K|Shiga, C|Sasano, H|Miyazaki, S|Yamamoto, T|Yamamoto, M|Hayashi, N|Nishihira, T|Mori, S
PMID: 7902061
Journal: Oncol Rep. 1995 May;2(3):381-5.
Title: Epidermal growth-factor receptors and erbb2 protein expression in esophageal cancer and normal mucosa.
Author: Dittadi, R|Ruol, A|Gion, M|Segalin, A|Panozzo, M|Brazzale, A|Meo, S|Ancona, E|Peracchia, A
PMID: 21597745
Journal: Cancer Res. 1997 Jan 1;57(1):28-31.
Title: Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma.
Author: Tanaka, S|Mori, M|Akiyoshi, T|Tanaka, Y|Mafune, K|Wands, J R|Sugimachi, K
PMID: 8988034
Journal: Cancer Res. 1997 Aug 15;57(16):3548-53.
Title: Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection method.
Author: Akiyama, N|Sasaki, H|Ishizuka, T|Kishi, T|Sakamoto, H|Onda, M|Hirai, H|Yazaki, Y|Sugimura, T|Terada, M
PMID: 9270027
Journal: Clin Cancer Res. 1999 Sep;5(9):2311-5.
Title: Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor.
Author: Pai-Scherf, L H|Villa, J|Pearson, D|Watson, T|Liu, E|Willingham, M C|Pastan, I
PMID: 10499598
Journal: World J Surg. 1999 Oct;23(10):1010-8.
Title: Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
Author: Friess, H|Fukuda, A|Tang, W H|Eichenberger, A|Furlan, N|Zimmermann, A|Korc, M|Buchler, M W
PMID: 10512940
Journal: J Biol Chem. 2000 Oct 6;275(40):30934-42.
Title: Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.
Author: Okano, J|Gaslightwala, I|Birnbaum, M J|Rustgi, A K|Nakagawa, H
PMID: 10908564
Journal: J Cutan Pathol. 2001 Sep;28(8):425-31.
Title: Metastatic adenocarcinoma of the esophagus to the skin: new patterns of tumor recurrence and alternate treatments for palliation.
Author: Smith, K J|Williams, J|Skelton, H
PMID: 11493381
Journal: Ann Thorac Surg. 2001 Sep;72(3):859-66.
Title: Tumor marker expression is predictive of survival in patients with esophageal cancer.
Author: Aloia, T A|Harpole, D H Jr|Reed, C E|Allegra, C|Moore, M B|Herndon, J E 2nd|D'Amico, T A
PMID: 11565671
Journal: World J Gastroenterol. 2003 Jun;9(6):1156-64.
Title: Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
Author: Wang, Li-Dong|Zheng, Shu|Zheng, Zuo-Yu|Casson, Alan G
PMID: 12800215
Journal: Gan To Kagaku Ryoho. 2003 Oct;30(11):1780-3.
Title: [Effect of trastuzumab for human esophageal cancer].
Author: Yamazaki, Masanao|Yamashita, Yoshito|Kubo, Naoshi|Ohira, Masaichi|Hirakawa, Kosei
PMID: 14619518
Journal: Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1323-7.
Title: c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.
Author: Akamatsu, Masayuki|Matsumoto, Toshiharu|Oka, Kuniyuki|Yamasaki, Shigetaka|Sonoue, Hiroshi|Kajiyama, Yoshiaki|Tsurumaru, Masahiko|Sasai, Keisuke
PMID: 14630269
Journal: Ann Thorac Surg. 2004 Mar;77(3):1008-15.
Title: Gene expression profiles in esophageal adenocarcinoma.
Author: Dahlberg, Peter S|Ferrin, Lance F|Grindle, Suzanne M|Nelson, Curtis M|Hoang, Chuong D|Jacobson, Blake
PMID: 14992916
Journal: Ann Thorac Surg. 2004 Nov;78(5):1790-800.
Title: ERBB2 amplifications in esophageal adenocarcinoma.
Author: Dahlberg, Peter S|Jacobson, Blake A|Dahal, Ganesh|Fink, James M|Kratzke, Robert A|Maddaus, Michael A|Ferrin, Lance J
PMID: 15511476
Journal: Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):203-11.
Title: Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein.
Author: Sato, Shinsuke|Kajiyama, Yoshiaki|Sugano, Masahiko|Iwanuma, Yoshimi|Sonoue, Hiroshi|Matsumoto, Toshiharu|Sasai, Keisuke|Tsurumaru, Masahiko
PMID: 15629613
Journal: Pathol Int. 2005 Feb;55(2):53-62.
Title: Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
Author: Bahnassy, Abeer A|Zekri, Abdel-Rahman N|Abdallah, Samira|El-Shehaby, Amal M R|Sherif, Ghada M
PMID: 15693850
Journal: J Am Coll Surg. 2005 Mar;200(3):336-44.
Title: Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Author: Schneider, Sylke|Uchida, Kazumi|Brabender, Jan|Baldus, Stephan E|Yochim, JiMin|Danenberg, Kathleen D|Salonga, Dennis|Chen, Pei|Tsao-Wei, Denice|Groshen, Susan|Hoelscher, Arnulf H|Schneider, Paul M|Danenberg, Peter V
PMID: 15737843
Journal: Cancer Res. 2005 Sep 1;65(17):8049-56.
Title: Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Author: Hou, Zhe|Sang, Shengmin|You, Hui|Lee, Mao-Jung|Hong, Jungil|Chin, Khew-Voon|Yang, Chung S
PMID: 16140980
Journal: Cancer Genet Cytogenet. 2006 Feb;165(1):41-50.
Title: Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Author: Bizari, Lucimari|Borim, Aldenis Albanese|Leite, Katia Ramos Moreira|Goncalves, Fernanda de Toledo|Cury, Patricia Maluf|Tajara, Eloiza Helena|Silva, Ana Elizabete
PMID: 16490596
Journal: Oncol Rep. 2007 Apr;17(4):887-93.
Title: The pan-erbB tyrosine kinase inhibitor CI-1033 inhibits human esophageal cancer cells in vitro and in vivo.
Author: Ako, E|Yamashita, Y|Ohira, M|Yamazaki, M|Hori, T|Kubo, N|Sawada, T|Hirakawa, K
PMID: 17342332
Journal: Anticancer Res. 2007 Jan-Feb;27(1B):505-11.
Title: Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
Author: Naritaka, Yoshihiko|Ogawa, Kenji|Shimakawa, Takeshi|Wagatsuma, Yoshihisa|Isohata, Noriyuki|Asaka, Shiniichi|Miyaki, Akira|Shiozawa, Shunichi|Katsube, Takao|Yoshimatsu, Kazuhiko|Aiba, Motohiko|Ide, Hiroko
PMID: 17348434
Journal: Int J Cancer. 2008 May 15;122(10):2249-54.
Title: Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues.
Author: Chen, Jing|Guo, Liping|Peiffer, Daniel A|Zhou, Lixin|Chan, Owen Tsan Mo|Bibikova, Marina|Wickham-Garcia, Eliza|Lu, Shih-Hsin|Zhan, Qimin|Wang-Rodriguez, Jessica|Jiang, Wei|Fan, Jian-Bing
PMID: 18241037
Journal: Cancer Cell. 2008 May;13(5):441-53.
Title: Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.
Author: Stoecklein, Nikolas H|Hosch, Stefan B|Bezler, Martin|Stern, Franziska|Hartmann, Claudia H|Vay, Christian|Siegmund, Annika|Scheunemann, Peter|Schurr, Paulus|Knoefel, Wolfram T|Verde, Pablo E|Reichelt, Uta|Erbersdobler, Andreas|Grau, Roger|Ullrich, Axel|Izb
PMID: 18455127
Journal: Gastroenterology. 2008 Sep;135(3):1000-2; discussion 1002-3.
Title: HER2 amplification in micrometastatic esophageal cancer cells predicts prognosis.
Author: Grugan, Katharine D|Nakagawa, Hiroshi
PMID: 18691587
Journal: Dis Esophagus. 2009;22(6):496-504.
Title: Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis.
Author: Boone, J|van Hillegersberg, R|Offerhaus, G J A|van Diest, P J|Borel Rinkes, I H M|Ten Kate, F J W
PMID: 19302210
Journal: Vaccine. 2009 Nov 16;27(49):6854-61.
Title: Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.
Author: Aoki, Masatoshi|Ueda, Shugo|Nishikawa, Hiroyoshi|Kitano, Shigehisa|Hirayama, Michiko|Ikeda, Hiroaki|Toyoda, Hideki|Tanaka, Kyosuke|Kanai, Michiyuki|Takabayashi, Arimichi|Imai, Hiroshi|Shiraishi, Taizo|Sato, Eiichi|Wada, Hisashi|Nakayama, Eiichi|Takei, Yos
PMID: 19761832
Journal: Genet Mol Biol. 2009 Apr;32(2):242-50.
Title: Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression.
Author: Bizari, Lucimari|Tajara, Eloiza Helena|Silva, Ana Elizabete
PMID: 21637674
Journal: Int J Cancer. 2010 Oct 15;127(8):1931-40.
Title: Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Author: Kalinina, Tatyana|Bockhorn, Maximilian|Kaifi, Jussuf T|Thieltges, Sabrina|Gungor, Cenap|Effenberger, Katharina E|Strelow, Andrea|Reichelt, Uta|Sauter, Guido|Pantel, Klaus|Izbicki, Jakob R|Yekebas, Emre F
PMID: 20104520
Journal: J Clin Oncol. 2010 Sep 1;28(25):3965-72.
Title: Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors.
Author: Yap, Timothy A|Vidal, Laura|Adam, Jan|Stephens, Peter|Spicer, James|Shaw, Heather|Ang, Jooern|Temple, Graham|Bell, Susan|Shahidi, Mehdi|Uttenreuther-Fischer, Martina|Stopfer, Peter|Futreal, Andrew|Calvert, Hilary|de Bono, Johann S|Plummer, Ruth
PMID: 20679611
Journal: J Gastrointest Surg. 2011 Jan;15(1):48-56.
Title: Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.
Author: Boonstra, Jurjen J|van Marion, Ronald|Tilanus, Hugo W|Dinjens, Winand N M
PMID: 20922573
Journal: Int J Cancer. 2011 Nov 15;129(10):2408-16.
Title: Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines.
Author: Mimura, Kousaku|Kono, Koji|Maruyama, Takanori|Watanabe, Mitsuaki|Izawa, Shinichiro|Shiba, Shugo|Mizukami, Yoshiki|Kawaguchi, Yoshihiko|Inoue, Masayuki|Kono, Tetsuo|Choudhury, Aniruddha|Kiessling, Rolf|Fujii, Hideki
PMID: 21207425
Journal: Ann Surg Oncol. 2011 Jul;18(7):2010-7.
Title: Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
Author: Thompson, Sarah K|Sullivan, Thomas R|Davies, Ruth|Ruszkiewicz, Andrew R
PMID: 21267790
Journal: BMC Cancer. 2011 Apr 11;11:126.
Title: Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.
Author: Andolfo, Immacolata|Petrosino, Giuseppe|Vecchione, Loredana|De Antonellis, Pasqualino|Capasso, Mario|Montanaro, Donatella|Gemei, Marica|Troncone, Giancarlo|Iolascon, Achille|Orditura, Michele|Ciardiello, Fortunato|De Vita, Fernando|Zollo, Massimo
PMID: 21481261
Journal: Biomark Med. 2011 Jun;5(3):307-18.
Title: Update on HER2 testing for breast and upper gastrointestinal tract cancers.
Author: Ross, Jeffrey S
PMID: 21657840
Journal: Curr Protoc Pharmacol. 2011 Sep;Chapter 14:Unit14.20.
Title: Orthotopic models of esophageal carcinoma and their use in drug discovery.
Author: Gros, Stephanie J
PMID: 21898333
Journal: Med Oncol. 2012 Jun;29(2):933-40.
Title: Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.
Author: Zhan, Na|Dong, Wei-Guo|Tang, Yong-Fei|Wang, Ze-Sheng|Xiong, Cheng-Long
PMID: 21318736
Journal: Biotech Histochem. 2012 Jan;87(1):40-5.
Title: HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options.
Author: Koltz, B R|Hicks, D G|Whitney-Miller, C L
PMID: 21745161
Journal: Crit Rev Oncol Hematol. 2012 Jun;82(3):310-22.
Title: Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.
Author: Maresch, Judith|Schoppmann, Sebastian F|Thallinger, Christiane M R|Zielinski, Christoph C|Hejna, Michael
PMID: 21783379
Journal: Breast Cancer Res Treat. 2012 Jan;131(1):217-22.
Title: Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients.
Author: Noh, Jae Myoung|Choi, Doo Ho|Nam, Seok Jin|Lee, Jeong Eon|Kim, Jong Won|Kim, Sung-Won|Kang, Eunyoung|Lee, Min Hyuk|Ahn, Sei Hyun|Kim, Ku Sang|Park, Sue K|Haffty, Bruce G
PMID: 21847643
Journal: Oncol Rep. 2012 May;27(5):1639-45.
Title: Lapatinib, a dual inhibitor of EGFR and HER2, has synergistic effects with 5-fluorouracil on esophageal carcinoma.
Author: Guo, Xiao-Fang|Zhu, Xiao-Fei|Zhong, Gen-Shen|Deng, Bao-Guo|Gao, Zhi-Tao|Wang, Hui
PMID: 22293713
Journal: Ann Thorac Surg. 2012 Apr;93(4):1101-6.
Title: Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma.
Author: Bandla, Santhoshi|Pennathur, Arjun|Luketich, James D|Beer, David G|Lin, Lin|Bass, Adam J|Godfrey, Tony E|Litle, Virginia R
PMID: 22450065
Journal: Curr Oncol Rep. 2012 Aug;14(4):342-9.
Title: Current developments in the management of locally advanced esophageal cancer.
Author: McNamara, Michael J|Adelstein, David J
PMID: 22544559
Journal: Cancer Res. 2012 Sep 1;72(17):4383-93. Epub 2012 Jul 2.
Title: Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
Author: Dulak, Austin M|Schumacher, Steven E|van Lieshout, Jasper|Imamura, Yu|Fox, Cameron|Shim, Byoungyong|Ramos, Alex H|Saksena, Gordon|Baca, Sylvan C|Baselga, Jose|Tabernero, Josep|Barretina, Jordi|Enzinger, Peter C|Corso, Giovanni|Roviello, Franco|Lin, Lin|Ba
PMID: 22751462
Journal: Cancer Gene Ther. 2012 Sep;19(9):609-18.
Title: Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Author: Issaenko, O A|Bitterman, P B|Polunovsky, V A|Dahlberg, P S
PMID: 22767218
Journal: Curr Top Med Chem. 2012;12(15):1678-82.
Title: Targetting esophageal and gastric cancers with monoclonal antibodies.
Author: Norguet, Emmanuelle|Dahan, Laetitia|Seitz, Jean-Francois
PMID: 22978338
Journal: Pathologe. 2012 Nov;33 Suppl 2:253-7.
Title: [Update on Barrett esophagus and Barrett carcinoma].
Author: Werner, M|Lassmann, S
PMID: 23011020
Journal: Tumori. 2012 Jul-Aug;98(4):451-7.
Title: Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.
Author: Schena, Marina|La Rovere, Erika|Solerio, Dino|Bustreo, Sara|Barone, Carla|Daniele, Lorenzo|Buffoni, Lucio|Bironzo, Paolo|Sapino, Anna|Gasparri, Guido|Ciuffreda, Libero|Ricardi, Umberto
PMID: 23052161
Journal: PLoS One. 2012;7(10):e47287.
Title: Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
Author: Gros, Stephanie J|Kurschat, Nina|Drenckhan, Astrid|Dohrmann, Thorsten|Forberich, Evelyn|Effenberger, Katharina|Reichelt, Uta|Hoffman, Robert M|Pantel, Klaus|Kaifi, Jussuf T|Izbicki, Jakob R
PMID: 23082154
Journal: Recent Results Cancer Res. 2012;196:107-13.
Title: Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
Author: Ruschoff, J
PMID: 23129369
Journal: Dis Esophagus. 2013 Jul;26(5):487-95.
Title: Lapatinib, a dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2, potentiates the antitumor effects of cisplatin on esophageal carcinoma.
Author: Guo, X F|Zhu, X F|Zhong, G S|Deng, B G
PMID: 22458639
Journal: Pathol Res Pract. 2013 Jan 15;209(1):6-9.
Title: Correlation analysis of c-myc, p21(WAF/CIP1), p53, C-erbB-2 and COX-2 proteins in esophageal squamous cell carcinoma.
Author: Gomes, Thiago Simao|Noguti, Juliana|Forones, Nora Manoukian|Lima, Flavio Oliveira|Dobo, Cristine|Fernandes Junior, Joao Antao|Oshima, Celina Tizuko Fujiyama|Ribeiro, Daniel Araki
PMID: 23177619
Journal: Semin Radiat Oncol. 2013 Jan;23(1):31-7.
Title: Targeted therapies with chemoradiation in esophageal cancer: development and future directions.
Author: Hong, Theodore S|Wo, Jennifer Y|Kwak, Eunice L
PMID: 23207045
Journal: Hepatogastroenterology. 2013 Jan-Feb;60(121):99-106.
Title: Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.
Author: Wu, Dongping|Xu, Jing|Yu, Guangmao|Zhang, Bicheng|Wang, Haiyong|Wang, Cheng|Ru, Guomei|Sun, Aijing|Shen, Li|Wei, Qichun
PMID: 23419663
Journal: Am J Surg Pathol. 2013 Apr;37(4):467-83.
Title: Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases.
Author: Huang, Qin|Wu, Hongyan|Nie, Ling|Shi, Jiong|Lebenthal, Abraham|Chen, Jieyu|Sun, Qi|Yang, Jun|Huang, Lily|Ye, Qing
PMID: 23426118
Journal: Eur J Immunol. 2013 Apr;43(4):989-1000.
Title: Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
Author: Hirayama, Michiko|Nishikawa, Hiroyoshi|Nagata, Yasuhiro|Tsuji, Takemasa|Kato, Takuma|Kageyama, Shinichi|Ueda, Shugo|Sugiyama, Daisuke|Hori, Sahoko|Sakaguchi, Shimon|Ritter, Gerd|Old, Lloyd J|Gnjatic, Sacha|Shiku, Hiroshi
PMID: 23436617
Journal: Int J Biol Markers. 2013 Apr 23;28(1):71-83.
Title: The expression of Egfl7 in human normal tissues and epithelial tumors.
Author: Fan, Chun|Yang, Lian-Yue|Wu, Fan|Tao, Yi-Ming|Liu, Lin-Sen|Zhang, Jin-Fan|He, Ya-Ning|Tang, Li-Li|Chen, Guo-Dong|Guo, Lei
PMID: 23558933
Journal: J Thorac Oncol. 2013 Jun;8(6):673-84.
Title: Chemotherapeutic and targeted strategies for locally advanced and metastatic esophageal cancer.
Author: Forde, Patrick M|Kelly, Ronan J
PMID: 23591158
Journal: Expert Opin Emerg Drugs. 2013 Jun;18(2):219-30.
Title: Emerging tyrosine kinase inhibitors for esophageal cancer.
Author: Ku, Geoffrey Y|Ilson, David H
PMID: 23725567
Journal: PLoS One. 2013 May 30;8(5):e63780.
Title: Testing the utility of an integrated analysis of copy number and transcriptomics datasets for inferring gene regulatory relationships.
Author: Goh, Xin Yi|Newton, Richard|Wernisch, Lorenz|Fitzgerald, Rebecca
PMID: 23737949
Journal: Gan To Kagaku Ryoho. 2013 Aug;40(8):1089-92.
Title: [A case of advanced esophagogastric junction cancer responding to pre-operative combination chemotherapy of docetaxel, cisplatin, S-1, and trastuzumab].
Author: Haruki, Shigeo|Takiguchi, Noriaki|Arita, Kaida|Usui, Shinsuke|Ito, Koji|Matsumoto, Akiyo|Hiranuma, Susumu|Bhunachet, Ekapot
PMID: 23986058
Journal: Int J Oncol. 2013 Dec;43(6):1745-53.
Title: Preoperative treatment of locally advanced esophageal carcinoma (Review).
Author: Orditura, Michele|Galizia, Gennaro|Fabozzi, Alessio|Lieto, Eva|Gambardella, Valentina|Morgillo, Floriana|Del Genio, Gian Mattia|Fei, Landino|Di Martino, Natale|Renda, Andrea|Ciardiello, Fortunato|De Vita, Ferdinando
PMID: 24100679
Journal: Expert Rev Anticancer Ther. 2013 Oct;13(10):1169-80.
Title: Advances in biomarkers for esophageal cancer.
Author: Nagaraja, Vinayak|Eslick, Guy D
PMID: 24134419
Journal: Anticancer Res. 2013 Nov;33(11):4975-82.
Title: Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
Author: Konig, Alexandra M|Reeh, Matthias|Dancau, Ana-Maria|Rathjens, Merrit|Gros, Stephanie|Uzunoglu, Faik G|Bockhorn, Maximilian|Simon, Ronald|Sauter, Guido|Marx, Andreas|Izbicki, Jakob R
PMID: 24222138
Journal: J Immunol. 2013 Dec 15;191(12):6261-72.
Title: The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Author: Mimura, Kousaku|Shiraishi, Kensuke|Mueller, Anja|Izawa, Shinichiro|Kua, Ley-Fang|So, Jimmy|Yong, Wei-Peng|Fujii, Hideki|Seliger, Barbara|Kiessling, Rolf|Kono, Koji
PMID: 24244023
Journal: J Gastrointest Oncol. 2014 Feb;5(1):25-35.
Title: HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.
Author: Gowryshankar, Ashwini|Nagaraja, Vinayak|Eslick, Guy D
PMID: 24490040
Journal: Int J Cancer. 2014 Oct 1;135(7):1517-30.
Title: EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
Author: Fichter, Christiane Daniela|Timme, Sylvia|Braun, Julia Alexandra|Gudernatsch, Verena|Schopflin, Anja|Bogatyreva, Lioudmilla|Geddert, Helene|Faller, Gerhard|Klimstra, David|Tang, Laura|Hauschke, Dieter|Werner, Martin|Lassmann, Silke
PMID: 24510732
Journal: PLoS One. 2014 Mar 24;9(3):e92986.
Title: An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.
Author: Guo, Xiao-Fang|Zhu, Xiao-Fei|Yang, Wan-Cai|Zhang, Sheng-Hua|Zhen, Yong-Su
PMID: 24664246
Journal: Int J Biol Markers. 2014 Sep 30;29(3):e268-78.
Title: The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression.
Author: Cheng, Min|Chen, Yongyan|Zou, Dehong|Shen, Guodong|Bian, Geng|Shen, Gan|Hu, Shilian
PMID: 24706379
Journal: Curr Treat Options Oncol. 2014 Sep;15(3):395-404.
Title: HER2 directed therapy for gastric/esophageal cancers.
Author: Won, Elizabeth|Janjigian, Yelena J|Ilson, David H
PMID: 24811128
Journal: Am Soc Clin Oncol Educ Book. 2014:e172-8.
Title: New directions in perioperative management of locally advanced esophagogastric cancer.
Author: Burtness, Barbara|Ilson, David|Iqbal, Syma
PMID: 24857100
Journal: Lab Invest. 2014 Aug;94(8):917-26.
Title: Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.
Author: Zhang, Jingchuan|Jiang, Dongxian|Li, Xiaojing|Lv, Jing|Xie, Liang|Zheng, Li|Gavine, Paul R|Hu, Qin|Shi, Yuan|Tan, Lijie|Ge, Di|Xu, Songtao|Li, Leon|Zhu, Lifang|Hou, Yingyong|Wang, Qun
PMID: 24999713
Journal: Gastrointest Endosc. 2014 Dec;80(6):984-91.
Title: Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.
Author: Timmer, Margriet R|Brankley, Shannon M|Gorospe, Emmanuel C|Sun, Gang|Lutzke, Lori S|Iyer, Prasad G|Halling, Kevin C|Krishnadath, Kausilia K|Wang, Kenneth K
PMID: 25085335
Journal: J Mol Med (Berl). 2014 Nov;92(11):1209-23.
Title: ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.
Author: Fichter, Christiane D|Gudernatsch, Verena|Przypadlo, Camilla M|Follo, Marie|Schmidt, Gudula|Werner, Martin|Lassmann, Silke
PMID: 25091467
Journal: Expert Opin Ther Targets. 2014 Dec;18(12):1421-6.
Title: The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?
Author: Uzunoglu, Faik G|Koenig, Alexandra M|Izbicki, Jakob R
PMID: 25256600
Journal: World J Gastroenterol. 2014 Oct 28;20(40):14904-12.
Title: MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
Author: Hummel, Richard|Sie, Corina|Watson, David I|Wang, Tingting|Ansar, Alfiya|Michael, Michael Z|Van der Hoek, Mark|Haier, Joerg|Hussey, Damian J
PMID: 25356050
Journal: J Gastrointest Oncol. 2014 Dec;5(6):E103-8.
Title: HER2-positive, trastuzumab-resistant metastatic esophageal cancer presenting with brain metastasis after durable response to dual HER2 blockade: a case report.
Author: Niu, Jiaxin|Gelbspan, Deborah|Weitz, David|Markman, Maurie|Quan, Walter Jr
PMID: 25436131
Journal: Ann Oncol. 2015 Apr;26(4):624-44.
Title: A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Author: Findlay, J M|Middleton, M R|Tomlinson, I
PMID: 25214541
Journal: Cell Signal. 2015 Feb;27(2):373-81.
Title: ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.
Author: Kebenko, Maxim|Drenckhan, Astrid|Gros, Stephanie J|Jucker, Manfred|Grabinski, Nicole|Ewald, Florian|Grottke, Astrid|Schultze, Alexander|Izbicki, Jakob R|Bokemeyer, Carsten|Wellbrock, Jasmin|Fiedler, Walter
PMID: 25435423
Journal: Oncologist. 2015 Jan;20(1):7-12.
Title: Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Author: Chmielecki, Juliann|Ross, Jeffrey S|Wang, Kai|Frampton, Garrett M|Palmer, Gary A|Ali, Siraj M|Palma, Norma|Morosini, Deborah|Miller, Vincent A|Yelensky, Roman|Lipson, Doron|Stephens, Philip J
PMID: 25480824
Journal: Eur J Cancer. 2015 Mar;51(5):569-76.
Title: Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Author: Lorenzen, Sylvie|Riera Knorrenschild, Jorge|Haag, Georg-Martin|Pohl, Michael|Thuss-Patience, Peter|Bassermann, Florian|Helbig, Ulrike|Weissinger, Florian|Schnoy, Elisabeth|Becker, Klaus|Stocker, Gertraud|Ruschoff, Josef|Eisenmenger, Andreas|Karapanagiotou
PMID: 25694417
Journal: Cancer Biol Ther. 2015;16(5):764-9.
Title: Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
Author: Miura, John T|Xiu, Joanne|Thomas, James|George, Ben|Carron, Benjamin R|Tsai, Susan|Johnston, Fabian M|Turaga, Kiran K|Gamblin, T Clark
PMID: 25778705
Journal: PLoS One. 2015 Mar 31;10(3):e0121872.
Title: Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.
Author: Dodbiba, Lorin|Teichman, Jennifer|Fleet, Andrew|Thai, Henry|Starmans, Maud H W|Navab, Roya|Chen, Zhuo|Girgis, Hala|Eng, Lawson|Espin-Garcia, Osvaldo|Shen, Xiaowei|Bandarchi, Bizhan|Schwock, Joerg|Tsao, Ming-Sound|El-Zimaity, Hala|Der, Sandy D|Xu, Wei|Bris
PMID: 25826681
Journal: J Gastrointest Oncol. 2015 Apr;6(2):143-54.
Title: HER2 expression in gastric and oesophageal cancer: a meta-analytic review.
Author: Nagaraja, Vinayak|Eslick, Guy D
PMID: 25830034
Journal: Oncologist. 2015 Oct;20(10):1132-9.
Title: Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Author: Wang, Kai|Johnson, Adrienne|Ali, Siraj M|Klempner, Samuel J|Bekaii-Saab, Tanios|Vacirca, Jeffrey L|Khaira, Depinder|Yelensky, Roman|Chmielecki, Juliann|Elvin, Julia A|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Ross, Jeffrey S
PMID: 26336083
Journal: J Gastrointest Surg. 2015 Dec;19(12):2105-10.
Title: Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy.
Author: Bronson, Nathan W|Diggs, Brian S|Bakis, Gene|Gatter, Kenneth M|Sheppard, Brett C|Hunter, John G|Dolan, James P
PMID: 26394876
Journal: Conn Med. 2015 Aug;79(7):401-4.
Title: Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma.
Author: Narra, Ravi K|Alvarez Argote, Juliana|Mesologites, Thalia|Dasanu, Constantin A
PMID: 26411176
Journal: Biomed Opt Express. 2015 Sep 1;6(10):3714-23.
Title: In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles.
Author: Wang, Yu Winston|Kang, Soyoung|Khan, Altaz|Bao, Philip Q|Liu, Jonathan T C
PMID: 26504623
Journal: Viszeralmedizin. 2015 Oct;31(5):341-6.
Title: Perioperative and Palliative Chemotherapy for Esophageal Cancer.
Author: Behrens, Angelika|Ell, Christian|Lordick, Florian
PMID: 26989390
Journal: Curr Drug Targets. 2016;17(15):1818-1826.
Title: Gastric Carcinoma at the Era of Targeted Therapies.
Author: Dreanic, Johann|Dhooge, Marion|Sion, Elena|Brezault, Catherine|Chaussade, Stanislas|Coriat, Romain
PMID: 25944013
Journal: Expert Opin Biol Ther. 2016;16(2):243-53.
Title: Pertuzumab in gastrointestinal cancer.
Author: Oh, Do-Youn|Bang, Yung-Jue
PMID: 26619359
Journal: Cancer Res. 2016 Apr 1;76(7):1714-23.
Title: Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.
Author: Hu, Nan|Kadota, Mitsutaka|Liu, Huaitian|Abnet, Christian C|Su, Hua|Wu, Hailong|Freedman, Neal D|Yang, Howard H|Wang, Chaoyu|Yan, Chunhua|Wang, Lemin|Gere, Sheryl|Hutchinson, Amy|Song, Guohong|Wang, Yuan|Ding, Ti|Qiao, You-Lin|Koshiol, Jill|Dawsey, Sanford
PMID: 26857264
Journal: Oncotarget. 2016 Mar 1;7(9):10243-54.
Title: ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.
Author: Ebbing, Eva A|Medema, Jan Paul|Damhofer, Helene|Meijer, Sybren L|Krishnadath, Kausilia K|van Berge Henegouwen, Mark I|Bijlsma, Maarten F|van Laarhoven, Hanneke W M
PMID: 26863569
Journal: Gastroenterology. 2016 May;150(5):1171-1182.
Title: Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.
Author: Sawada, Genta|Niida, Atsushi|Uchi, Ryutaro|Hirata, Hidenari|Shimamura, Teppei|Suzuki, Yutaka|Shiraishi, Yuichi|Chiba, Kenichi|Imoto, Seiya|Takahashi, Yusuke|Iwaya, Takeshi|Sudo, Tomoya|Hayashi, Tomoatsu|Takai, Hiroki|Kawasaki, Yoshihiro|Matsukawa, Takashi
PMID: 26873401
Journal: Expert Rev Gastroenterol Hepatol. 2016;10(5):595-604.
Title: Targeted therapy in esophageal cancer.
Author: Zhang, Lei|Ma, Jiaojiao|Han, Yu|Liu, Jinqiang|Zhou, Wei|Hong, Liu|Fan, Daiming
PMID: 26895097
Journal: Sci Rep. 2016 May 3;6:25467.
Title: Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.
Author: Werner, Simone|Chen, Hongda|Butt, Julia|Michel, Angelika|Knebel, Phillip|Holleczek, Bernd|Zornig, Inka|Eichmuller, Stefan B|Jager, Dirk|Pawlita, Michael|Waterboer, Tim|Brenner, Hermann
PMID: 27140836
Journal: Oncotarget. 2016 Jun 28;7(26):39680-39693.
Title: MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
Author: Lin, Cheng-Han|Tsai, Chen-Hsun|Yeh, Ching-Tung|Liang, Jui-Lin|Hung, Wan-Chun|Lin, Forn-Chia|Chang, Wei-Lun|Li, Hao-Yi|Yao, Yun-Chin|Hsu, Tai-I|Lee, Yu-Cheng|Wang, Yi-Ching|Sheu, Bor-Shyang|Lai, Wu-Wei|Calkins, Marcus J|Hsiao, Michael|Lu, Pei-Jung
PMID: 27203740
Journal: Minerva Med. 2016 Oct;107(5):328-41. Epub 2016 Jun 16.
Title: Role of human epidermal growth factor receptor 2 as a prognostic factor for survival in esophageal carcinoma: evidence from 2872 subjects.
Author: Wang, Wen J|Wu, Min J|Chang, Jia|Xie, Peng|Lu, Zhi Q|Ren, Jing L
PMID: 27309036
Journal: Clin Cancer Res. 2016 Sep 1;22(17):4283-90.
Title: New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints.
Author: Wang, Victoria E|Grandis, Jennifer R|Ko, Andrew H
PMID: 27370606
Journal: Curr Opin Gastroenterol. 2016 Nov;32(6):501-506.
Title: An update in the nonendoscopic treatment of gastric cancer.
Author: Ilson, David H
PMID: 27636304
Journal: Ann Surg. 2016 Nov;264(5):839-846.
Title: Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study.
Author: Bollschweiler, Elfriede|Holscher, Arnulf H|Herbold, Till|Metzger, Ralf|Alakus, Hakan|Schmidt, Henner|Drebber, Uta|Warnecke-Eberz, Ute
PMID: 27741011
Journal: Biomed Khim. 2016 Jul;62(5):520-526.
Title: [Epigenetic markers of esophageal cancer: DNA methylation].
Author: Kit, O I|Vodolazhskiy, D I|Kolesnikov, E N|Timoshkina, N N
PMID: 27797326
Journal: Onco Targets Ther. 2016 Nov 25;9:7235-7245.
Title: Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives.
Author: Davidson, Michael|Starling, Naureen
PMID: 27932891
Journal: Am J Transl Res. 2016 Dec 15;8(12):5729-5740. eCollection 2016.
Title: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.
Author: Wu, Jianzhong|Li, Shuchun|Ma, Rong|Sharma, Ashok|Bai, Shan|Dun, Boying|Cao, Haixia|Jing, Changwen|She, Jinxiong|Feng, Jifeng
PMID: 28078044
Journal: Mol Cancer Ther. 2017 Jan;16(1):228-238.
Title: HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib.
Author: Press, Michael F|Ellis, Catherine E|Gagnon, Robert C|Grob, Tobias J|Buyse, Marc|Villalobos, Ivonne|Liang, Zhiyong|Wu, Shafei|Bang, Yung-Jue|Qin, Shu-Kui|Chung, Hyun Cheol|Xu, Jianming|Park, Joon Oh|Jeziorski, Krzysztof|Afenjar, Karen|Ma, Yanling|Estrada,
PMID: 27811012
Journal: Oncotarget. 2017 Jan 31;8(5):8536-8549.
Title: The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKalpha/mTOR pathway in vitro and in vivo.
Author: Fujihara, Shintaro|Morishita, Asahiro|Ogawa, Kana|Tadokoro, Tomoko|Chiyo, Taiga|Kato, Kiyohito|Kobara, Hideki|Mori, Hirohito|Iwama, Hisakazu|Masaki, Tsutomu
PMID: 28052030
Journal: Future Oncol. 2017 Apr;13(10):919-934.
Title: Translating genomic profiling to gastrointestinal cancer treatment.
Author: Harada, Kazuto|Mizrak Kaya, Dilsa|Shimodaira, Yusuke|Song, Shumei|Baba, Hideo|Ajani, Jaffer A
PMID: 28067073
Journal: World J Surg. 2017 Jul;41(7):1719-1725.
Title: Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
Author: Iams, Wade T|Villaflor, Victoria M
PMID: 28271259
Journal: Gastroenterology. 2017 Jul;153(1):63-76.e14.
Title: Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Author: Ebbing, Eva A|Steins, Anne|Fessler, Evelyn|Stathi, Phylicia|Lesterhuis, Willem Joost|Krishnadath, Kausilia K|Vermeulen, Louis|Medema, Jan Paul|Bijlsma, Maarten F|van Laarhoven, Hanneke W M
PMID: 28286209
Journal: Cancer Prev Res (Phila). 2017 May;10(5):308-318.
Title: The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4'-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth.
Author: Lim, Tae-Gyu|Lee, Sung-Young|Duan, Zhaoheng|Lee, Mee-Hyun|Chen, Hanyong|Liu, Fangfang|Liu, Kangdong|Jung, Sung Keun|Kim, Dong Joon|Bode, Ann M|Lee, Ki Won|Dong, Zigang
PMID: 28325828
Journal: Digestion. 2017;95(4):253-261.
Title: Esophageal Cancer: New Insights into a Heterogenous Disease.
Author: Krug, Sebastian|Michl, Patrick
PMID: 28384630
Journal: Expert Opin Investig Drugs. 2017 May;26(5):531-540.
Title: Perspectives of HER2-targeting in gastric and esophageal cancer.
Author: Gerson, James N|Skariah, Sam|Denlinger, Crystal S|Astsaturov, Igor
PMID: 28387541
Journal: Sci Rep. 2017 Apr 12;7(1):854.
Title: The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives.
Author: Li, Lin|Yue, Grace Gar-Lee|Lee, Julia Kin-Ming|Wong, Eric Chun-Wai|Fung, Kwok-Pui|Yu, Jun|Lau, Clara Bik-San|Chiu, Philip Wai-Yan
PMID: 28405006
Journal: Oncotarget. 2017 May 2;8(18):29846-29856.
Title: Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines.
Author: Hartmans, Elmire|Linssen, Matthijs D|Sikkens, Claire|Levens, Afra|Witjes, Max J H|van Dam, Gooitzen M|Nagengast, Wouter B
PMID: 28415738
Journal: Gastroenterology. 2018 Jan;154(2):437-451.
Title: Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
Author: Ilson, David H|van Hillegersberg, Richard
PMID: 29037469
Journal: Int J Cancer. 2018 Feb 15;142(4):833-843.
Title: Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
Author: Hoffmann, Martin|Pasch, Sophie|Schamberger, Thomas|Maneck, Matthias|Mohlendick, Birte|Schumacher, Sarah|Brockhoff, Gero|Knoefel, Wolfram Trudo|Izbicki, Jakob|Polzer, Bernhard|Stoecklein, Nikolas H|Klein, Christoph A
PMID: 29044505
Journal: Ann Thorac Surg. 2018 Feb;105(2):363-370.
Title: HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
Author: Goltsov, Alexei A|Fang, Bingliang|Pandita, Tej K|Maru, Dipen M|Swisher, Stephen G|Hofstetter, Wayne L
PMID: 29223420
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):185-189.
Title: [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Author: Dong, Ruizeng|Zhang, Zewei|Zhou, Yiming|Hua, Yonghong|Guo, Jianmin
PMID: 29492918
Journal: Eur J Surg Oncol. 2018 Aug;44(8):1191-1198.
Title: Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Author: Carmona-Bayonas, Alberto|Jimenez-Fonseca, Paula|Echavarria, Isabel|Sanchez Canovas, Manuel|Aguado, Gema|Gallego, Javier|Custodio, Ana|Hernandez, Raquel|Viudez, Antonio|Cano, Juana Maria|Martinez de Castro, Eva|Macias, Ismael|Martin Carnicero, Alfonso|Garr
PMID: 29685755
Journal: Front Immunol. 2018 Apr 19;9:814.
Title: Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing gammadelta T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.
Author: Oberg, Hans H|Kellner, Christian|Gonnermann, Daniel|Sebens, Susanne|Bauerschlag, Dirk|Gramatzki, Martin|Kabelitz, Dieter|Peipp, Matthias|Wesch, Daniela
PMID: 29725336
Journal: Oncotarget. 2018 Apr 20;9(30):21141-21155.
Title: Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.
Author: Sauveur, Juliette|Matera, Eva-Laure|Chettab, Kamel|Valet, Philippe|Guitton, Jerome|Savina, Ariel|Dumontet, Charles
PMID: 29765526
Journal: J Enzyme Inhib Med Chem. 2018 Dec;33(1):1024-1033.
Title: CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
Author: Drenckhan, Astrid|Freytag, Morton|Supuran, Claudiu T|Sauter, Guido|Izbicki, Jakob R|Gros, Stephanie J
PMID: 29865880
Journal: J Immunol. 2018 Oct 1;201(7):2165-2175.
Title: miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism.
Author: Zhang, Tengfei|Zhang, Zhen|Li, Feng|Ping, Yu|Qin, Guohui|Zhang, Chaoqi|Zhang, Yi
PMID: 30150287
Journal: Anticancer Res. 2018 Oct;38(10):5665-5669.
Title: Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
Author: Woestemeier, Anna|Ghadban, Tarik|Riethdorf, Sabine|Harms-Effenberger, Katharina|Konczalla, Leonie|Uzunoglu, Faik G|Izbicki, Jakob R|Pantel, Klaus|Bockhorn, Maximilian|Reeh, Matthias
PMID: 30275185